BRCA Methylation Testing Identifies a Subset of Ovarian Carcinomas without Germline Variants That Can Benefit from PARP InhibitorNora Sahnane, Maria Grazia Tibiletti, Sofia Facchi et al.|International Journal of Molecular Sciences|2020Cited by 55
Targeted molecular profiling of epithelial ovarian cancer from Italian BRCA wild-type patients with a BRCA and PARP pathways gene panelAnnamaria Salvati, Francesca Rizzo, Ileana Carnevali et al.|Experimental and Molecular Pathology|2022Cited by 3